K-1022

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameK-1022
Drug Alias Namecannabidiol prodrug (Kalytera Therapeutics)bi-sulfate derivative of cannabidiol (Kalytera Therapeutics)K-1022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid modulators
TargetsUpdating
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClaritas Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesClaritas Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A